Bausch + Lomb Corporation (BLCO) News

Bausch + Lomb Corporation (BLCO): $15.02

0.31 (+2.11%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Filter BLCO News Items

BLCO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest BLCO News From Around the Web

Below are the latest news stories about BAUSCH & LOMB CORP that investors may wish to consider to help them evaluate BLCO as an investment opportunity.

Bausch + Lomb CEO Brent Saunders Pays $35.35 Million for Cher’s Former Miami Beach Home

Bausch + Lomb CEO Brent Saunders has purchased Cher’s former waterfront home in Miami Beach, Fla., for $35.35 million. The La Gorce Island home, which Cher owned in the 1990s, hit the market three months ago for $42.5 million. Saunders, who is also the former CEO of the Botox maker Allergan, said he bought the property with his wife, Daniela Botero Correa.

Yahoo | November 28, 2023

Is Bausch + Lomb Corporation (NYSE:BLCO) Trading At A 39% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Bausch + Lomb fair value estimate is US$25.50 Current share...

Yahoo | November 21, 2023

Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

VAUGHAN, Ontario, November 15, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE and Biotrue Eye Care Recycling programs have collected a total of 76,645,000 million units, or 464,100 pounds, of used contact lenses, eye care and lens care materials in the United States, which is equivalent to the weight of 140 hippos1.

Yahoo | November 15, 2023

Bausch & Lomb Corp (BLCO) Reports Q3 2023 Earnings and Raises Full-Year Guidance

Revenue Grows 7% to $1.007 Billion, Despite Net Loss of $84 Million

Yahoo | November 1, 2023

Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance

VAUGHAN, Ontario, November 01, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2023 financial results.

Yahoo | November 1, 2023

Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting

VAUGHAN, Ontario, October 26, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced three podium presentations and seven poster presentations during the American Academy of Ophthalmology (AAO) annual meeting, which will take place in San Francisco Nov. 3-6, 2023.

Yahoo | October 26, 2023

Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1

VAUGHAN, Ontario, October 16, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter 2023 financial results on Wednesday, Nov. 1, 2023. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of

Yahoo | October 16, 2023

Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting

VAUGHAN, Ontario, October 04, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced one podium presentation and four poster presentations during the American Academy of Optometry (AAOpt) annual meeting, which will take place in New Orleans Oct. 11-14, 2023.

Yahoo | October 4, 2023

Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)

LAVAL, QC / ACCESSWIRE / September 29, 2023 / Bausch + Lomb Corporation ("Bausch + Lomb") (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc. (the "Company" or "Bausch Health") (NYSE/TSX:BHC), today announced it has completed its acquisition ...

Yahoo | September 29, 2023

Bausch + Lomb Completes Acquisition of XIIDRA®

VAUGHAN, Ontario, September 29, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced it has completed its acquisition of XIIDRA (lifitegrast ophthalmic solution) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease (DED) focusing on inflammation associated with dry eye, and certain other ophthalmology assets.

Yahoo | September 29, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!